ICD18108J ;ALB/JDG - YEARLY DRG UPDATE; October 01, 2020@15:42
;;18.0;DRG Grouper;**108**;October 20, 2000;Build 3
;
; Updates for DRGS 640-809
Q
;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
;;640^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC^1.2308^3.3
;;641^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC^0.7542^2.6
;;642^10^MED^INBORN AND OTHER DISORDERS OF METABOLISM^1.2898^3.3
;;643^10^MED^ENDOCRINE DISORDERS WITH MCC^1.6677^5.0
;;644^10^MED^ENDOCRINE DISORDERS WITH CC^1.0198^3.5
;;645^10^MED^ENDOCRINE DISORDERS WITHOUT CC/MCC^0.7686^2.7
;;650^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC^4.5207^6.8
;;651^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC^3.6984^6.0
;;652^11^SURG^KIDNEY TRANSPLANT^3.1851^4.7
;;653^11^SURG^MAJOR BLADDER PROCEDURES WITH MCC^5.4592^10.2
;;654^11^SURG^MAJOR BLADDER PROCEDURES WITH CC^2.9028^5.6
;;655^11^SURG^MAJOR BLADDER PROCEDURES WITHOUT CC/MCC^2.0803^3.6
;;656^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC^3.2850^5.6
;;657^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC^1.9347^3.2
;;658^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC^1.5779^2.1
;;659^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC^2.6664^5.9
;;660^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC^1.4431^3.1
;;661^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC^1.0637^1.9
;;662^11^SURG^MINOR BLADDER PROCEDURES WITH MCC^2.9373^6.9
;;663^11^SURG^MINOR BLADDER PROCEDURES WITH CC^1.5995^3.7
;;664^11^SURG^MINOR BLADDER PROCEDURES WITHOUT CC/MCC^1.1838^1.9
;;665^11^SURG^PROSTATECTOMY WITH MCC^3.0417^7.6
;;666^11^SURG^PROSTATECTOMY WITH CC^1.7397^4.0
;;667^11^SURG^PROSTATECTOMY WITHOUT CC/MCC^0.9975^2.0
;;668^11^SURG^TRANSURETHRAL PROCEDURES WITH MCC^2.8063^7.1
;;669^11^SURG^TRANSURETHRAL PROCEDURES WITH CC^1.5635^3.8
;;670^11^SURG^TRANSURETHRAL PROCEDURES WITHOUT CC/MCC^0.9785^2.1
;;671^11^SURG^URETHRAL PROCEDURES WITH CC/MCC^1.7813^3.9
;;672^11^SURG^URETHRAL PROCEDURES WITHOUT CC/MCC^1.1504^1.6
;;673^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC^3.4683^7.7
;;674^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC^2.3832^5.9
;;675^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC^1.7547^2.7
;;682^11^MED^RENAL FAILURE WITH MCC^1.4727^4.3
;;683^11^MED^RENAL FAILURE WITH CC^0.8793^3.1
;;684^11^MED^RENAL FAILURE WITHOUT CC/MCC^0.6079^2.2
;;686^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC^1.8753^5.0
;;687^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH CC^1.0501^3.3
;;688^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC^0.6858^1.9
;;689^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITH MCC^1.1142^3.8
;;690^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC^0.7940^2.9
;;693^11^MED^URINARY STONES WITH MCC^1.3355^3.7
;;694^11^MED^URINARY STONES WITHOUT MCC^0.7712^2.1
;;695^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC^1.1377^3.6
;;696^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC^0.6919^2.3
;;697^11^MED^URETHRAL STRICTURE^0.9993^2.8
;;698^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC^1.6106^4.7
;;699^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC^1.0270^3.3
;;700^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC^0.7465^2.4
;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES WITH CC/MCC^1.9222^2.5
;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC^1.4912^1.4
;;709^12^SURG^PENIS PROCEDURES WITH CC/MCC^2.3159^4.0
;;710^12^SURG^PENIS PROCEDURES WITHOUT CC/MCC^1.6016^1.7
;;711^12^SURG^TESTES PROCEDURES WITH CC/MCC^2.1316^5.3
;;712^12^SURG^TESTES PROCEDURES WITHOUT CC/MCC^1.0600^2.5
;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY WITH CC/MCC^1.4934^2.8
;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC^0.9288^1.6
;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC^2.0216^5.0
;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC^1.2758^1.4
;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC^1.8006^3.7
;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC^1.2346^2.2
;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC^1.7126^5.1
;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC^1.0919^3.5
;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6481^1.8
;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY WITH MCC^1.2855^4.0
;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC^0.7447^2.5
;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC^1.4210^4.4
;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC^0.8057^3.0
;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC^1.0075^3.1
;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC^0.5689^1.8
;;734^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC^2.2243^3.5
;;735^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC^1.4136^1.7
;;736^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC^4.2607^8.4
;;737^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC^2.0581^4.2
;;738^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.4759^2.6
;;739^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC^3.8240^6.6
;;740^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC^1.8016^2.8
;;741^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.2799^1.6
;;742^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC^1.7181^2.8
;;743^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC^1.1328^1.7
;;744^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC^1.7954^4.4
;;745^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC^1.1700^2.2
;;746^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC^1.6115^3.2
;;747^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC^0.9391^1.5
;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^1.3476^1.6
;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC^2.7138^5.6
;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC^1.4638^2.3
;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.8262^5.0
;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.1293^3.3
;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.9184^2.1
;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.5247^4.7
;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC^0.9697^3.6
;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6834^2.7
;;760^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC^0.9201^2.6
;;761^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC^0.5908^1.8
;;768^14^SURG^VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C^1.1696^3.1
;;769^14^SURG^POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES^1.6176^2.9
;;770^14^SURG^ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^0.8898^1.8
;;776^14^MED^POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES^0.7745^2.5
;;779^14^MED^ABORTION WITHOUT D&C^1.0590^2.0
;;783^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH MCC^1.8749^4.8
;;784^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH CC^1.0959^3.3
;;785^14^SURG^CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC^0.9168^2.7
;;786^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH MCC^1.5944^4.3
;;787^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH CC^1.0644^3.5
;;788^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC^0.8874^3.0
;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.7200^1.8
;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^5.6721^17.9
;;791^15^MED^PREMATURITY WITH MAJOR PROBLEMS^3.8738^13.3
;;792^15^MED^PREMATURITY WITHOUT MAJOR PROBLEMS^2.3374^8.6
;;793^15^MED^FULL TERM NEONATE WITH MAJOR PROBLEMS^3.9792^4.7
;;794^15^MED^NEONATE WITH OTHER SIGNIFICANT PROBLEMS^1.4084^3.4
;;795^15^MED^NORMAL NEWBORN^0.1907^3.1
;;796^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC^1.0708^3.6
;;797^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC^0.9194^2.4
;;798^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC^0.8275^2.1
;;799^16^SURG^SPLENECTOMY WITH MCC^5.1474^7.8
;;800^16^SURG^SPLENECTOMY WITH CC^2.9539^5.0
;;801^16^SURG^SPLENECTOMY WITHOUT CC/MCC^1.6840^2.6
;;802^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC^3.7117^7.5
;;803^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC^1.8865^3.9
;;804^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC^1.3659^2.0
;;805^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC^1.0299^2.9
;;806^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC^0.7346^2.3
;;807^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC^0.6423^2.1
;;808^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC^2.1858^5.4
;;809^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC^1.2234^3.5
;;EXIT
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD18108J 9910 printed Dec 13, 2024@01:47:57 Page 2
ICD18108J ;ALB/JDG - YEARLY DRG UPDATE; October 01, 2020@15:42
+1 ;;18.0;DRG Grouper;**108**;October 20, 2000;Build 3
+2 ;
+3 ; Updates for DRGS 640-809
+4 QUIT
+5 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
+1 ;;640^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC^1.2308^3.3
+2 ;;641^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC^0.7542^2.6
+3 ;;642^10^MED^INBORN AND OTHER DISORDERS OF METABOLISM^1.2898^3.3
+4 ;;643^10^MED^ENDOCRINE DISORDERS WITH MCC^1.6677^5.0
+5 ;;644^10^MED^ENDOCRINE DISORDERS WITH CC^1.0198^3.5
+6 ;;645^10^MED^ENDOCRINE DISORDERS WITHOUT CC/MCC^0.7686^2.7
+7 ;;650^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC^4.5207^6.8
+8 ;;651^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC^3.6984^6.0
+9 ;;652^11^SURG^KIDNEY TRANSPLANT^3.1851^4.7
+10 ;;653^11^SURG^MAJOR BLADDER PROCEDURES WITH MCC^5.4592^10.2
+11 ;;654^11^SURG^MAJOR BLADDER PROCEDURES WITH CC^2.9028^5.6
+12 ;;655^11^SURG^MAJOR BLADDER PROCEDURES WITHOUT CC/MCC^2.0803^3.6
+13 ;;656^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC^3.2850^5.6
+14 ;;657^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC^1.9347^3.2
+15 ;;658^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC^1.5779^2.1
+16 ;;659^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC^2.6664^5.9
+17 ;;660^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC^1.4431^3.1
+18 ;;661^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC^1.0637^1.9
+19 ;;662^11^SURG^MINOR BLADDER PROCEDURES WITH MCC^2.9373^6.9
+20 ;;663^11^SURG^MINOR BLADDER PROCEDURES WITH CC^1.5995^3.7
+21 ;;664^11^SURG^MINOR BLADDER PROCEDURES WITHOUT CC/MCC^1.1838^1.9
+22 ;;665^11^SURG^PROSTATECTOMY WITH MCC^3.0417^7.6
+23 ;;666^11^SURG^PROSTATECTOMY WITH CC^1.7397^4.0
+24 ;;667^11^SURG^PROSTATECTOMY WITHOUT CC/MCC^0.9975^2.0
+25 ;;668^11^SURG^TRANSURETHRAL PROCEDURES WITH MCC^2.8063^7.1
+26 ;;669^11^SURG^TRANSURETHRAL PROCEDURES WITH CC^1.5635^3.8
+27 ;;670^11^SURG^TRANSURETHRAL PROCEDURES WITHOUT CC/MCC^0.9785^2.1
+28 ;;671^11^SURG^URETHRAL PROCEDURES WITH CC/MCC^1.7813^3.9
+29 ;;672^11^SURG^URETHRAL PROCEDURES WITHOUT CC/MCC^1.1504^1.6
+30 ;;673^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC^3.4683^7.7
+31 ;;674^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC^2.3832^5.9
+32 ;;675^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC^1.7547^2.7
+33 ;;682^11^MED^RENAL FAILURE WITH MCC^1.4727^4.3
+34 ;;683^11^MED^RENAL FAILURE WITH CC^0.8793^3.1
+35 ;;684^11^MED^RENAL FAILURE WITHOUT CC/MCC^0.6079^2.2
+36 ;;686^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC^1.8753^5.0
+37 ;;687^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH CC^1.0501^3.3
+38 ;;688^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC^0.6858^1.9
+39 ;;689^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITH MCC^1.1142^3.8
+40 ;;690^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC^0.7940^2.9
+41 ;;693^11^MED^URINARY STONES WITH MCC^1.3355^3.7
+42 ;;694^11^MED^URINARY STONES WITHOUT MCC^0.7712^2.1
+43 ;;695^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC^1.1377^3.6
+44 ;;696^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC^0.6919^2.3
+45 ;;697^11^MED^URETHRAL STRICTURE^0.9993^2.8
+46 ;;698^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC^1.6106^4.7
+47 ;;699^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC^1.0270^3.3
+48 ;;700^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC^0.7465^2.4
+49 ;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES WITH CC/MCC^1.9222^2.5
+50 ;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC^1.4912^1.4
+51 ;;709^12^SURG^PENIS PROCEDURES WITH CC/MCC^2.3159^4.0
+52 ;;710^12^SURG^PENIS PROCEDURES WITHOUT CC/MCC^1.6016^1.7
+53 ;;711^12^SURG^TESTES PROCEDURES WITH CC/MCC^2.1316^5.3
+54 ;;712^12^SURG^TESTES PROCEDURES WITHOUT CC/MCC^1.0600^2.5
+55 ;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY WITH CC/MCC^1.4934^2.8
+56 ;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC^0.9288^1.6
+57 ;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC^2.0216^5.0
+58 ;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC^1.2758^1.4
+59 ;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC^1.8006^3.7
+60 ;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC^1.2346^2.2
+61 ;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC^1.7126^5.1
+62 ;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC^1.0919^3.5
+63 ;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6481^1.8
+64 ;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY WITH MCC^1.2855^4.0
+65 ;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC^0.7447^2.5
+66 ;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC^1.4210^4.4
+67 ;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC^0.8057^3.0
+68 ;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC^1.0075^3.1
+69 ;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC^0.5689^1.8
+70 ;;734^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC^2.2243^3.5
+71 ;;735^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC^1.4136^1.7
+72 ;;736^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC^4.2607^8.4
+73 ;;737^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC^2.0581^4.2
+74 ;;738^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.4759^2.6
+75 ;;739^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC^3.8240^6.6
+76 ;;740^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC^1.8016^2.8
+77 ;;741^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.2799^1.6
+78 ;;742^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC^1.7181^2.8
+79 ;;743^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC^1.1328^1.7
+80 ;;744^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC^1.7954^4.4
+81 ;;745^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC^1.1700^2.2
+82 ;;746^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC^1.6115^3.2
+83 ;;747^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC^0.9391^1.5
+84 ;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^1.3476^1.6
+85 ;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC^2.7138^5.6
+86 ;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC^1.4638^2.3
+87 ;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.8262^5.0
+88 ;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.1293^3.3
+89 ;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.9184^2.1
+90 ;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.5247^4.7
+91 ;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC^0.9697^3.6
+92 ;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6834^2.7
+93 ;;760^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC^0.9201^2.6
+94 ;;761^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC^0.5908^1.8
+95 ;;768^14^SURG^VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C^1.1696^3.1
+96 ;;769^14^SURG^POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES^1.6176^2.9
+97 ;;770^14^SURG^ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^0.8898^1.8
+98 ;;776^14^MED^POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES^0.7745^2.5
+99 ;;779^14^MED^ABORTION WITHOUT D&C^1.0590^2.0
+100 ;;783^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH MCC^1.8749^4.8
+101 ;;784^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH CC^1.0959^3.3
+102 ;;785^14^SURG^CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC^0.9168^2.7
+103 ;;786^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH MCC^1.5944^4.3
+104 ;;787^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH CC^1.0644^3.5
+105 ;;788^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC^0.8874^3.0
+106 ;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.7200^1.8
+107 ;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^5.6721^17.9
+108 ;;791^15^MED^PREMATURITY WITH MAJOR PROBLEMS^3.8738^13.3
+109 ;;792^15^MED^PREMATURITY WITHOUT MAJOR PROBLEMS^2.3374^8.6
+110 ;;793^15^MED^FULL TERM NEONATE WITH MAJOR PROBLEMS^3.9792^4.7
+111 ;;794^15^MED^NEONATE WITH OTHER SIGNIFICANT PROBLEMS^1.4084^3.4
+112 ;;795^15^MED^NORMAL NEWBORN^0.1907^3.1
+113 ;;796^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC^1.0708^3.6
+114 ;;797^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC^0.9194^2.4
+115 ;;798^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC^0.8275^2.1
+116 ;;799^16^SURG^SPLENECTOMY WITH MCC^5.1474^7.8
+117 ;;800^16^SURG^SPLENECTOMY WITH CC^2.9539^5.0
+118 ;;801^16^SURG^SPLENECTOMY WITHOUT CC/MCC^1.6840^2.6
+119 ;;802^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC^3.7117^7.5
+120 ;;803^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC^1.8865^3.9
+121 ;;804^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC^1.3659^2.0
+122 ;;805^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC^1.0299^2.9
+123 ;;806^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC^0.7346^2.3
+124 ;;807^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC^0.6423^2.1
+125 ;;808^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC^2.1858^5.4
+126 ;;809^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC^1.2234^3.5
+127 ;;EXIT
